Quantcast

Posts related to ‘Adnexus’

IPO FILING: Adnexus Therapeutics, Targeting Avastin (ADNX, BMY)

ADNEXUS THERAPEUTICS, INC. has filed to come public via an IPO with the filed amount to sell up to $86,250,000 in common stock.  Adnexus has taken the proposed ADNX ticker ...
Read Full Story »